{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Oklahoma City",
      "state": "OK",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72942",
      "recalling_firm": "PD-Rx Pharmaceuticals, Inc.",
      "address_1": "727 N Ann Arbor Ave",
      "address_2": "N/A",
      "postal_code": "73127-5822",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Alabama",
      "recall_number": "D-0559-2016",
      "product_description": "Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01",
      "product_quantity": "9 bottles",
      "reason_for_recall": "cGMP Deviations",
      "recall_initiation_date": "20150710",
      "center_classification_date": "20151231",
      "termination_date": "20170308",
      "report_date": "20160106",
      "code_info": "Lot# B14D26, Exp 02/16"
    }
  ]
}